Highlights

  • AML3D shares were flat at AUD 0.20 on 27 April 2026 despite a favourable quarterly update.
  • Customer receipts reached $2.2 million in Q3 FY26, with year-to-date receipts up 20% to $6.9 million.
  • Total orders in hand stood at $29 million as of 31 March 2026.
  • The company secured $9.9 million in ARCEMY® system orders from a major US shipbuilder.
  • Cash position remained at $26.5 million, supporting expansion plans.
  • Ongoing investments in US expansion and R&D impacted operating cash flow.

AML3D Ltd (ASX:AL3) shares were trading flat at AUD 0.20 during the morning session on 27 April 2026, following the release of its quarterly activities report for the period ended 31 March 2026 (Q3 FY26). The lack of immediate share price movement comes despite the company reporting several favourable operational developments, including increased customer receipts and a growing order book.

The muted market response appears to reflect a balance between favourable order momentum and ongoing investment-related cash outflows, as the company continues to expand its manufacturing capacity and execute its growth strategy.

Company Overview and Technology Focus

AML3D operates in the advanced manufacturing sector, specialising in large-scale metal 3D printing using its proprietary Wire Additive Manufacturing (WAM) technology. The company is the original equipment manufacturer of ARCEMY, an industrial 3D printing system designed to produce metal components on demand.

Its technology integrates robotics, welding science, materials engineering and software systems, enabling applications across industries such as defence, aerospace, energy, mining, and oil and gas. AML3D’s solutions are positioned to offer efficiency and flexibility compared to traditional manufacturing methods such as casting and forging.

Customer Receipts and Order Book Growth Support Momentum

During Q3 FY26, AML3D recorded customer receipts of $2.2 million, maintaining a consistent run rate over the previous three quarters. Year-to-date customer receipts reached $6.9 million, representing a 20% increase compared to the prior corresponding period.

A key highlight from the quarter was the continued expansion of the company’s order book, with total orders in hand reaching $29 million as of 31 March 2026. This includes $20 million of orders secured during FY26, combined with $9 million carried into the financial year.

The order book growth reflects ongoing demand for ARCEMY systems and additive manufacturing solutions, particularly within the United States defence sector.

Major US Defence Orders Drive Growth Strategy

AML3D’s US expansion strategy remains a central component of its growth trajectory. During the quarter, the company secured a $9.9 million order for four ARCEMY systems from Newport News Shipbuilding, part of the largest military shipbuilder in the United States. This follows an earlier $4.5 million order for two systems from the same customer, indicating an increase in deployment scale over a relatively short period.

In addition, AML3D received a $2.6 million order for five non-safety critical submarine components for the US Navy. These components address supply chain challenges where original equipment manufacturers are no longer supporting certain parts.

The company also completed the commissioning of a $1.7 million ARCEMY system for FasTech, a supplier to the US defence, aerospace, and energy sectors. This project adds to AML3D’s presence across both defence and industrial markets.

Expansion of US Operations and Capacity Investment

To support growing demand, AML3D is expanding its manufacturing capacity in the United States, particularly at its facility in Stow, Ohio. The company has committed $12 million to this expansion, with $0.8 million invested during the March quarter as the initial phase.

This expansion is intended to enable the company to deliver its existing order book while accommodating further anticipated demand from the US Navy and broader industrial manufacturing sectors.

The company also continues to engage with the US Navy’s Maritime Industrial Base, where ARCEMY technology is being deployed across submarine, surface fleet, and munitions programs.

Advocacy and Market Penetration Initiatives

AML3D has entered a new phase of its US advocacy program aimed at increasing its penetration within the US defence supply chain. During the quarter, the company appointed a new US Defence advisor, Larissa Smith, who previously served as Director of Additive Manufacturing for the US Navy.

This initiative is designed to expand AML3D’s engagement with key stakeholders and decision-makers, facilitating broader adoption of its ARCEMY technology across defence applications.

The company has already established relationships with major defence contractors and continues to leverage these connections to support its growth strategy.

Expansion into UK and European Defence Markets

Beyond the United States, AML3D is progressing its entry into the UK and European defence markets. During the quarter, the company continued work on a $1.2 million material feasibility and testing program with BAE Systems in the UK.

The company is also engaged in early-stage negotiations for ARCEMY system sales in the region and has undertaken confidential manufacturing work for a UK-based defence supplier.

To support this expansion, AML3D plans to establish a European Technology Centre with a planned investment of $5 million, most likely located in the UK. Distribution agreements have already been signed to facilitate market entry across the region.

Australian Operations and Strategic Positioning

In Australia, AML3D completed the commissioning of a $1 million ARCEMY system for Curtin University during the quarter. This system is expected to serve as both a research platform and a demonstration facility for potential customers across industries including mining, agriculture, and oil and gas.

The company’s Australian operations also provide additional capacity to support international contracts, particularly those in the US and UK.

AML3D’s positioning within the AUKUS defence framework further supports its strategic outlook, with the company already recognised as a key exporter within this ecosystem.

Financial Position Reflects Investment Phase

From a financial perspective, AML3D reported operating cash outflows of $2.06 million during the quarter, reflecting increased production activity and investment in growth initiatives.

Product manufacturing and operating costs rose to $2.4 million compared to $0.1 million in the prior corresponding period, aligning with the higher volume of orders being executed.

In addition to operational spending, the company invested $0.27 million during the quarter in its ARCEMY Increase Deposition Rates (AIDR) research and development project. Total investment in this program during FY26 has reached $1 million out of a $2.24 million budget.

Despite these outflows, AML3D maintains a cash balance of $26.5 million, providing sufficient funding to support its expansion plans and ongoing operations.

Outlook Supported by Order Book and Expansion Plans

Looking ahead, AML3D’s outlook is supported by its existing $29 million order book and expectations of continued demand from defence and industrial sectors. The company is focused on executing its current orders while expanding capacity to capture additional opportunities.

The transition to a new phase of its US advocacy program, combined with early-stage demand in Europe, is expected to contribute to future order growth.

The company also highlighted its intention to leverage its experience in the US market to accelerate entry into European defence markets, applying a similar operational approach.

What This Means for Investors?

The flat share price reaction on 27 April 2026 suggests that the market is weighing AML3D’s favourable operational progress against the financial impact of its ongoing investment phase. While the company has demonstrated growth in orders and customer receipts, increased costs and cash outflows reflect its expansion strategy.

Investors may be focusing on the execution of the existing order book, the pace of revenue conversion, and the outcomes of capacity expansion initiatives. The balance between growth investments and financial performance is likely to remain a key consideration in the near term.